Ramatroban
SIGMA/R0531 - ≥98% (HPLC), solid
Synonym: (+)
CAS Number: 116649-85-5
Empirical Formula (Hill Notation): C21H21FN2O4S
Molecular Weight: 416.47
MDL Number: MFCD00887606
Linear Formula: C21H21FN2O4S
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white |
| form | solid |
| InChI | 1S/C21H21FN2O4S/c22-14-5- |
| InChI key | LDXDSHIEDAPSSA-OAHLLOKOSA |
| originator | Bayer |
| Quality Level | 100 ![]() |
| SMILES string | OC(=O)CCn1c2CC[C@H](Cc2c3 |
| solubility | DMSO: ≥40 mg/mL |
| H2O: insoluble | |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | Ramatroban aids in the reduction of myocardial ischemia-reperfusion injury, lipopolysaccharide-induce |
| Biochem/physiol Actions: | Ramatroban is used for the treatment of allergic rhinitis as an antagonist of the thromboxane receptor. |
| Biochem/physiol Actions: | Ramatroban is used for the treatment of allergic rhinitis as an antagonist of the thromboxane receptor. It is also an antagonist of the DP2 receptor with IC50 values of 100-170 nM. It is more potent at the DP2 receptor than the TP receptor by 4-5 fold. It is therefore a useful tool for the elucidation of PGD2/DP2 function in eosinophils, basophils, and other cells of the TH2 cell-type. |
| Features and Benefits: | This compound was developed by Bayer . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 |
| Precautionary statements | P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36/37/39-45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 1 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 51111800 |


